4//SEC Filing
Cadavid Diego 4
Accession 0001628280-22-002505
CIK 0001501697other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:19 PM ET
Size
5.3 KB
Accession
0001628280-22-002505
Insider Transaction Report
Form 4
Cadavid Diego
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-02-11−928→ 7,107 total
Footnotes (3)
- [F1]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.53 to $1.74, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Represents unvested restricted stock units.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001778713
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:19 PM ET
- Size
- 5.3 KB